Clinical Trial Update: Perioperative Treatment of High-risk Resectable CCA With HAIC Plus A+T: Neobrave CCA [Phase 2]

View source ↗

Summary

This clinical trial update reports termination of a Phase 2 study evaluating perioperative hepatic arterial infusion chemotherapy with A+T (Neobrave CCA) for hi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma
• Perihilar Cholangiocarcinoma

Drugs mentioned

• A+T
• HAIC (hepatic artery infusion chemotherapy)
• Neobrave CCA

Snippet

Sponsor: Peking University | Conditions: Intrahepatic Cholangiocarcinoma (Icc), Perihilar Cholangiocarcinoma | Phase 2 | Status: TERMINATED